Trend — Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous (G0328) in Medicare, the United States

The full twelve-year services and payments series for this market — per-year values, with the FFS-enrollment denominator beside each.

The compound annual growth for G0328 in the United States — endpoints exclude the introduction year; an Exclude 2020–21 view drops the pandemic years too.